Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Kiniksa Pharmaceuticals, Ltd. Income Statement Banner

Kiniksa Pharmaceuticals, Ltd. Income Statement

KNSA Stock Analysis

Page title

Section title

Breakdown
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
0.0000.0000.0000.0000.00038.544M220.180M270.259M
Cost of Revenue
22.000K28.000K286.000K3.279M3.805M9.100M46.966M91.040M
Gross Profit
-22.000k-28.000k-286.000k-3.279m-3.805m29.444M173.214M179.219M
Operating Expense
24.002M65.400M108.160M169.963M157.363M186.080M163.441M204.415M
Operating Income
-24.002m-65.400m-108.160m-169.963m-157.363m-156.636m7.371M-25.196m
Other Income Expense
0.0000.0000.0000.0000.000835.000K1.253M8.544M
Total Other Income Expense
65.000K529.000K4.719M6.049M1.134M97.000K3.655M8.544M
Pretax Income
-23.937m-64.871m-103.441m-163.914m-156.229m-156.539m11.026M-16.652m
Tax Provision
36.000K2.000K-214.000k-2.047m5.152M1.385M-172.337m-30.736m
Net Income
-23.973m-64.873m-103.227m-161.867m-161.381m-157.924m183.363M14.084M
Basic EPS
-0.740-2.000-3.490-2.990-2.610-2.3002.6400.200
Diluted EPS
-0.740-2.000-3.490-2.990-2.610-2.3002.6000.200
Basic Average Shares
32.467M32.467M29.547M54.049M61.843M68.577M69.382M70.059M
Diluted Average Shares
32.467M32.467M29.547M54.049M61.843M68.577M70.421M71.923M
Total Expenses
24.002M65.400M108.160M169.963M157.363M195.180M210.407M295.455M
Interest Income
65.000K529.000K4.719M6.049M1.134M97.000K1.253M8.544M
Interest Expense
0.0000.0000.0000.0000.0000.0001.253M0.000
EBITDA
-23.980m-65.372m-108.160m-169.963m-157.363m-156.636m9.773M-23.087m
Depreciation & Amortization
22.000K28.000K286.000K3.279M3.805M4.086M4.220M2.109M